HUANG Danqi, YANG Min, XIONG Wei, LIU Jingyi, CHEN Wanqing, ZHAI Jingbo, LI Jiang. Analysis of Disease Burden and Attributable Risk Factors of Early-onset Female Breast Cancer in China and Globally from 1990 to 2021[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-1083
Citation: HUANG Danqi, YANG Min, XIONG Wei, LIU Jingyi, CHEN Wanqing, ZHAI Jingbo, LI Jiang. Analysis of Disease Burden and Attributable Risk Factors of Early-onset Female Breast Cancer in China and Globally from 1990 to 2021[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-1083

Analysis of Disease Burden and Attributable Risk Factors of Early-onset Female Breast Cancer in China and Globally from 1990 to 2021

More Information
  • Received Date: December 18, 2024
  • Accepted Date: January 22, 2025
  • Available Online: March 04, 2025
  • Objective To analyze the disease burden, trends, and attributable risk factors of early-onset female breast cancer in China and globally from 1990 to 2021. Methods Data on the number and crude rates of incidence, death, and disability adjusted life year (DALY), and attributable proportion for DALY of five specific risk factors (tobacco, alcohol use, low physical activity, diet high in red meat, and high fasting plasma glucose) and all risk factors were extracted from the Global Burden of Disease 2021 (GBD 2021). The Joinpoint regression model was used to analyze the trends through annual percentage change (APC) and average annual percentage change (AAPC) on the trends of age-standardized rates. Results From 1990 to 2021, the age-standardized incidence rates in China and globally showed an overall upward trend (China: AAPC = 2.25%; Globally: AAPC = 0.64%; Pairwise comparison, P < 0.001). The age-standardized mortality rates (China: AAPC = -0.82%; Globally: AAPC = -0.26%; Pairwise comparison, P < 0.001) and agestandardized DALY rates (China: AAPC = -0.63%; Globally: AAPC = -0.18%; Pairwise comparison, P = 0.004) showed an overall downward trend. The age-standardized mortality rates (APC = 0.78%) and age-standardized DALY rates (APC = 1.38%) in China have shown a gradually upward trend since 2014 and 2015, respectively. The proportion of DALY attributed to diet high in red meat was relatively highest in China (13.55%) and globally (11.20%). Conclusion From 1990 to 2021, the age-standardized incidence rates of early-onset female breast cancer in China and globally showed an overall upward trend, and the age-standardized mortality rates and age-standardized DALY rates showed an overall downward trend. The age-standardized incidence rates in China was approaching to the global level, and the age-standardized mortality rates and age-standardized DALY rates have shown an upward trend in the past decade. The prevention and treatment of early-onset female breast cancer in China is in a serious situation. In the future, further expanding the promotion scope of female breast cancer screening programs, optimizing the female breast cancer screening programs, and improving residents' awareness of cancer prevention and treatment knowledge will help reduce the growing disease burden of early-onset female breast cancer in China.
  • Related Articles

    [1]ZHAO Xiaoxiao, LU Xiaohui, KE Lixin, GAO Wulin, MENG Xiangran, REN Lili, DING Yunhan, ZHANG Qiang, XUN Yangqin, WU Jibiao, LU Cuncun. Investigation and Trend Prediction of Disease Burden of Hypertension in the Elderly Population Globally and in China from 1990 to 2021[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-1005
    [2]TIAN Chen, YANG Shuihua, YANG Kehu, GE Long. Constructed the Global Health Policy and Management Evidence Clearinghouse to Facilitate Evidence-based Policymaking and Health Governance for Sustainable Development[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0763
    [3]SUN Wenjuan, ZHANG Bo. Current Situation and Implications of Novel Antitumer Drugs in China[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1036-1044. DOI: 10.12290/xhyxzz.2021-0521
    [4]CHEN Chen, HAN Xiaohong. Clinical Trials of Rare Diseases in China over One Decade: Based on the Chinese First List of Rare Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1028-1035. DOI: 10.12290/xhyxzz.2022-0010
    [5]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China(2021)(Ⅴ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 658-665. DOI: 10.12290/xhyxzz.20210005
    [6]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China(2021)(Ⅳ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 650-657. DOI: 10.12290/xhyxzz.20210004
    [7]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China(2021)(Ⅲ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 641-649. DOI: 10.12290/xhyxzz.20210003
    [8]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China (2021)(Ⅱ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 632-640. DOI: 10.12290/xhyxzz.20210002
    [9]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China (2021)(Ⅰ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 624-631. DOI: 10.12290/xhyxzz.20210001
    [10]Jing FAN, Xu-dong MA, Yan-hong GUO. Striking Improvements in the Technological Capability and the Quality of Healthcare in China[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(4): 303-306. DOI: 10.3969/j.issn.1674-9081.2018.04.004

Catalog

    Article Metrics

    Article views (108) PDF downloads (31) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close